Mirabegron
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure (NCT02775539) | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 2016-06-01 |
Track Mirabegron automatically
Every clearance here is in the API, with alerts when new ones post.